<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Su H</submitter><funding>KU Leuven</funding><funding>the Research Foundation Flanders</funding><funding>National Institute for Health Research (NIHR)</funding><funding>the China Scholarship Council</funding><funding>Wellcome Trust</funding><pagination>794-812</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7618761</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>47(7)</volume><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Maternal infections have been proposed to play a role in the development of congenital heart defects (CHD). This study aims to synthesize contemporary evidence on the association between first-trimester maternal infection and risk of offspring CHD.&lt;h4>Methods&lt;/h4>This systematic review and meta-analysis (PROSPERO number: CRD42024523638) used Embase, PubMed, Web of Science, Scopus, and the Cochrane Library to identify studies investigating first-trimester maternal infection and offspring CHD, published up until 30 September 2024. Human studies with a minimum of 50 cases were eligible. Inverse variance weighted random-effects models were conducted to pool estimates and stratify associations by infection type and heart defect type.&lt;h4>Results&lt;/h4>A total of 30 studies (24 case-control, 3 cohort, and 3 cross-sectional studies) with 1 732 295 pregnancies were identified. Studies assessed maternal infectious status through self-reported questionnaires (n = 20, 66.7%), laboratory testing (n = 7, 23.3%) or medical records (n = 3, 10.0%). Overall, any first-trimester maternal infection was associated with higher risk of CHD in offspring, with a pooled odds ratio (OR) and 95% confidence interval (CI) of 1.63 (1.41, 1.88). Among specific types of infection, rubella virus, coxsackievirus, respiratory infections, and influenza presented higher risks of offspring CHD, with ORs (95% CI) of 2.78 (2.08, 3.72), 1.57 (1.12, 2.19), 1.57 (1.25, 1.96), and 1.50 (1.20, 1.87), respectively. Studies that reported associations by individual subtype of CHD relied on a comparatively modest number of cases. Pooled ORs for exposure to any first-trimester infection were 1.59 (1.16, 2.20) for ventricular septal defects, 1.55 (1.21, 1.99) for atrioventricular septal defects, and not statistically significant for other subtypes.&lt;h4>Conclusions&lt;/h4>First-trimester maternal infections are associated with increased risk of offspring CHD and appear to extend beyond infections commonly tested for during routine pregnancy screening. Larger-scale studies are warranted to confirm these findings using laboratory antibody testing and explore underlying mechanisms.</pubmed_abstract><journal>European heart journal</journal><pubmed_title>First trimester maternal infections and offspring congenital heart defects: a meta-analysis.</pubmed_title><pmcid>PMC7618761</pmcid><funding_grant_id>318034/Z/24/Z</funding_grant_id><funding_grant_id>NIHR304997</funding_grant_id><pubmed_authors>Troost E</pubmed_authors><pubmed_authors>De Meester P</pubmed_authors><pubmed_authors>Woodward M</pubmed_authors><pubmed_authors>Chambers C</pubmed_authors><pubmed_authors>Van De Bruaene A</pubmed_authors><pubmed_authors>Schuermans A</pubmed_authors><pubmed_authors>Conrad N</pubmed_authors><pubmed_authors>Su H</pubmed_authors><pubmed_authors>He JR</pubmed_authors><pubmed_authors>Morten K</pubmed_authors><pubmed_authors>Dwyer T</pubmed_authors><pubmed_authors>Waterboer T</pubmed_authors><pubmed_authors>Rahimi K</pubmed_authors><pubmed_authors>Guo E</pubmed_authors><pubmed_authors>Budts W</pubmed_authors></additional><is_claimable>false</is_claimable><name>First trimester maternal infections and offspring congenital heart defects: a meta-analysis.</name><description>&lt;h4>Background and aims&lt;/h4>Maternal infections have been proposed to play a role in the development of congenital heart defects (CHD). This study aims to synthesize contemporary evidence on the association between first-trimester maternal infection and risk of offspring CHD.&lt;h4>Methods&lt;/h4>This systematic review and meta-analysis (PROSPERO number: CRD42024523638) used Embase, PubMed, Web of Science, Scopus, and the Cochrane Library to identify studies investigating first-trimester maternal infection and offspring CHD, published up until 30 September 2024. Human studies with a minimum of 50 cases were eligible. Inverse variance weighted random-effects models were conducted to pool estimates and stratify associations by infection type and heart defect type.&lt;h4>Results&lt;/h4>A total of 30 studies (24 case-control, 3 cohort, and 3 cross-sectional studies) with 1 732 295 pregnancies were identified. Studies assessed maternal infectious status through self-reported questionnaires (n = 20, 66.7%), laboratory testing (n = 7, 23.3%) or medical records (n = 3, 10.0%). Overall, any first-trimester maternal infection was associated with higher risk of CHD in offspring, with a pooled odds ratio (OR) and 95% confidence interval (CI) of 1.63 (1.41, 1.88). Among specific types of infection, rubella virus, coxsackievirus, respiratory infections, and influenza presented higher risks of offspring CHD, with ORs (95% CI) of 2.78 (2.08, 3.72), 1.57 (1.12, 2.19), 1.57 (1.25, 1.96), and 1.50 (1.20, 1.87), respectively. Studies that reported associations by individual subtype of CHD relied on a comparatively modest number of cases. Pooled ORs for exposure to any first-trimester infection were 1.59 (1.16, 2.20) for ventricular septal defects, 1.55 (1.21, 1.99) for atrioventricular septal defects, and not statistically significant for other subtypes.&lt;h4>Conclusions&lt;/h4>First-trimester maternal infections are associated with increased risk of offspring CHD and appear to extend beyond infections commonly tested for during routine pregnancy screening. Larger-scale studies are warranted to confirm these findings using laboratory antibody testing and explore underlying mechanisms.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-09T11:18:46.26Z</modification><creation>2026-07-09T10:43:24.661Z</creation></dates><accession>S-EPMC7618761</accession><cross_references><pubmed>40878857</pubmed><doi>10.1093/eurheartj/ehaf564</doi></cross_references></HashMap>